Researchers from Miami Cancer Institute, part of Baptist Health South Florida, today published a study in Trends in Cancer that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs).
Analyzing tissue-agnostic therapies for the treatment of primary brain tumors medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
<p>Researchers from Miami Cancer Institute, part of Baptist Health South Florida, today published a study in <em>Trends in Cancer</em> that analyzes the use of tissue-agnostic therapeutics in patients with primary brain tumors (PBTs).</p>
Immune checkpoint inhibitors and stereotactic radiosurgery do not increase the risk of necrosis among patients with NSCLC who have brain metastases, according to research.
Immune checkpoint inhibition with single fraction stereotactic radiosurgery does not increase risk of radiation necrosis medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.